Evaluation of the effect of CYP2D6*3, *4,*10, and *17 polymorphisms on the pharmacokinetic of tamoxifen and its metabolites in patients with hormone-positive breast cancer

Autor: Saghafi, Fatemeh, Salehifar, Ebrahim, Ebrahimi, Pouneh, Shiran, Mohammad Reza, Zaboli, Ehsan, Sohrevardi, Seyed Mojtaba, Jamialahmadi, Tannaz, Sahebnasagh, Adeleh, Sahebkar, Amirhossein
Zdroj: In Journal of Pharmaceutical and Biomedical Analysis 20 January 2024 238
Databáze: ScienceDirect